New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR Annual Meeting 2026
Go back to New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR Annual Meeting 2026| Nuvel Holdings, Inc. (NASDAQ: NUVL) | Delayed: 123.44 +0.02 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.42 | 52 Week High | $0.40 | |||
| Open | $123.49 | 52 Week Low | $0.14 | |||
| Day High | $123.52 | P/E | N/A | |||
| Day Low | $123.41 | EPS | $-0.56 | |||
| Volume | 1,335,904 | |||||
